Reaction
Hepatitis B Dna Increased reporting signals
As of the last recalculation, Hepatitis B Dna Increased appears in 666 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is ENTECAVIR (PRR 487.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Entecavir | 143 | 487.1 | 493.2 |
| Lamivudine Oral | 139 | 216.7 | 217.9 |
| Tenofovir Disoproxil Fumarate Tablets | 52 | 204.1 | 205.3 |
| Lamivudine | 145 | 187.2 | 188.1 |
| Tenofovir Disoproxil Fumarate | 126 | 146.7 | 147.3 |
| Darunavir | 21 | 44.8 | 44.8 |
| Raltegravir | 17 | 33.0 | 33.0 |
| Ritonavir 100 Mg | 14 | 29.9 | 29.9 |
| Atazanavir | 13 | 28.8 | 28.8 |
| Ritonavir | 22 | 24.3 | 24.3 |
| Baricitinib | 5 | 16.3 | 16.3 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 9 | 15.7 | 15.7 |
| Sofosbuvir | 9 | 14.4 | 14.4 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 19 | 13.4 | 13.4 |
| Ledipasvir And Sofosbuvir | 7 | 11.5 | 11.5 |
| Remdesivir | 4 | 9.4 | 9.4 |